| References |
| 18 June 2021 Risk assessment for SARS-CoV-2 variant: Delta (VOC-21APR-02, B.1.617.2) |
| A systematic review of antibody mediated immunity to
coronaviruses: kinetics, correlates of protection, and association with
severity |
| An early warning approach to monitor COVID-19 activity with multiple digital traces in near real time |
| Antibody responses to SARS-CoV-2 in patients with
COVID-19 |
Assessing the human immune response to SARS-CoV-2 variants
|
Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases
|
| Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China |
| Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China |
| Complement control for COVID-19 |
| Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition |
| Differential Effects of Intervention Timing on COVID 19 Spread in the United States |
| Diverse Functional Autoantibodies in Patients with COVID-19 |
| Early Transmission
Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia |
| Emergence and spread of a SARS-CoV-2 variant through Europe in the summer of 2020 |
| Estimating clinical severity of COVID-19 from the
transmission dynamics in Wuhan, China |
| Evaluating the impact of COVID-19 on male reproduction |
| Evidence of exposure to SARS-CoV-2 in cats and dogs from households in Italy |
| Evolutionary history, potential intermediate animal host,
and cross‐species analyses of SARS‐CoV‐2 |
| Exposure to air pollution and COVID-19 mortality in
the United States: A nationwide cross-sectional study |
| First Case of 2019 Novel
Coronavirus in the United States |
| From
SARS to COVID-19: A previously unknown SARS- related coronavirus
(SARS-CoV-2) of pandemic potential infecting humans – Call for a
OneHealth approach |
| Global Health Concern Stirred by Emerging Viral Infections |
| Hydroxychloroquine
for treatment of nonsevere COVID-19 patients: Systematic review and
meta-analysis of controlled clinical trials |
| Immunological characteristics govern the transition of COVID-19 to endemicity |
| Interpreting Diagnostic Tests for SARS-CoV-2 |
| Investigate the origins of COVID-19 |
| Lethal Pneumonia Cases in Mojiang Miners (2012) and the Mineshaft Could Provide Important Clues to the Origin of SARS-CoV-2 |
| Mechanism of SARS-CoV-2 polymerase stalling by remdesivir |
| Middle East Respiratory Syndrome Coronavirus: Another
Zoonotic Betacoronavirus Causing SARS-Like Disease |
| Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19) |
| Pangolins Lack IFIH1/MDA5, a Cytoplasmic RNA Sensor That Initiates Innate Immune Defense Upon Coronavirus Infection |
| Preexisting and de novo humoral immunity to SARS-CoV-2 in humans |
| Putative invasive pulmonary aspergillosis in critically ill patients with COVID‐19: An observational study from New York City |
| Recovery of deleted deep sequencing data sheds more light on the early Wuhan SARS-CoV-2 epidemic |
| Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19) |
| Report of the WHO-China
Joint Mission on Coronavirus Disease 2019 (COVID-19) |
| Respiratory
virus shedding in exhaled breath and efficacy of face masks |
| SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 Milan outbreak |
| SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies |
| SARS-like cluster of circulating bat coronavirus pose threat
for human emergence |
| Serological Evidence of Bat SARS-Related Coronavirus Infection in Humans, China |
| Severe Acute Respiratory Syndrome Coronavirus as an
Agent of Emerging and Reemerging Infection |
| Severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and
the challenges |
| Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’ |
| Susceptibility of Raccoon Dogs for Experimental SARS-CoV-2 Infection |
| TEMPORARY REMOVAL: Experimental Treatment with Favipiravir
for COVID-19: An Open-Label Control Study |
| The 2019‐new coronavirus epidemic: Evidencefor virus
evolution |
| The airborne lifetime of small speech droplets and
their potential importance in SARS-CoV-2 transmission |
| The Analysis of Six Patients With Severe Pneumonia Caused By Unknown Viruses |
| The early phase of the COVID-19 outbreak in Lombardy,
Italy |
| The
proximal origin of SARS-CoV-2 |
| The turning point and end of an expanding epidemiccannot be precisely forecast |
| Treatment of 5 Critically Ill Patients With COVID-19
With Convalescent Plasma |
| Understanding
of COVID‐19 based on current evidence |
| Unexpected Features of Cardiac Pathology in COVID-19 Infection |
| Virus - Dalla diffusione
di malattie
letali all’impatto sull’evoluzione della vita, la doppia faccia di
questi microrganismi |
| What
Scientists
Want to Know About the Coronavirus Outbreak |